NEVVI Medicare utilization intelligence
or browse by specialty
Medicare · fee-for-service Part B

Nuclear Medicine — Medicare Part B billing by state

$0.02B
Medicare payments
6
Physician groups
276,144
Services

6 physician groups whose primary specialty is Nuclear Medicine billed $0.02B to Medicare fee-for-service in 2024.

Calendar year 2024 · Medicare fee-for-service Part B

Physician groups whose primary specialty is Nuclear Medicine, by billing state · CY2024
State Groups Services Beneficiary-episodes Medicare payments Standardized payments ↓ Payments / group Services / group
Virginia 1 29,275 5,876 $7,291,402 $7,590,792 $7,291,402 29,275
California 1 73,671 14,618 $4,583,824 $4,687,220 $4,583,824 73,671
Florida 2 161,434 17,697 $2,443,852 $2,365,098 $1,221,926 80,717
New York 1 7,193 6,675 $964,722 $898,964 $964,722 7,193
South Carolina 1 3,797 1,302 $56,924 $63,417 $56,924 3,797
Washington 1 774 756 $22,667 $22,076 $22,667 774
Ranked by standardized payments — the cross-state basis (regional price differences removed). The Medicare payments column shows what Medicare actually paid. Each state opens the ranked Nuclear Medicine market for that state's biggest code.

Need this specialty's market in one document?

Notify me at launch

Each group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.

All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.

Top codes by Medicare payments CY2024

Code Services Medicare payments ↓ Largest state markets
78815 · Nuclear medicine study from skull base to mid-thigh with ct scan 7,405 $3,122,656 VACAFLNYSC
Q9983 · Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries 681 $1,709,561 VACAFLNYSC
A9595 · Piflufolastat f-18, diagnostic, 1 millicurie 3,283 $1,602,621 VACAFLNYSC
78814 · Nuclear medicine study limited area with ct scan 794 $1,166,913 VACAFLNYSC
78431 · Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan 475 $735,373 VACAFLNYSC
A9584 · Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries 343 $723,014 VACAFLNYSC
A9596 · Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie 680 $553,148 VACAFLNYSC
J9271 · Injection, pembrolizumab, 1 mg 10,600 $472,381 VACAFLNYSC
J0897 · Injection, denosumab, 1 mg 21,060 $431,513 VACAFLNYSC
78816 · Nuclear medicine study whole body with ct scan 1,369 $408,610 VACAFLNYSC
J1437 · Injection, ferric derisomaltose, 10 mg top by services 13,600 $215,560 VACAFLNYSC
96375 · Injection of additional new drug or substance into vein top by services 6,978 $91,030 VACAFLNYSC
85025 · Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count top by services 4,839 $36,721 VACAFLNYSC
Q5125 · Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram top by services 58,560 $22,219 VACAFLNYSC
A9577 · Injection, gadobenate dimeglumine (multihance), per ml top by services 5,218 $7,473 VACAFLNYSC
Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services 64,684 $6,679 VACAFLNYSC
J1453 · Injection, fosaprepitant, 1 mg top by services 8,100 $906 VACAFLNYSC
Top codes by Medicare payments and by services (both rankings, duplicates merged; capped, never the full code list). “top by services” marks codes here on service volume rather than payments. Each code is searchable free at full depth; state links open that code's ranked market page.

Every code above is searchable free at full depth. Ranking organizations across several codes at once — one combined market view — is part of a Nevvi subscription.

Notify me at launch